Skip to main content
. 2022 Apr 23;10(5):982. doi: 10.3390/biomedicines10050982

Figure 2.

Figure 2

Differences in bacterial microbiota diversity between COVID-19 patients and SARS-CoV-2-negative controls. (A,B) Alpha diversity in COVID-19 patients and SARS-CoV-2-negative controls at bacterial genus (A) and species (B) level assessed by microbial richness, Shannon and Simpson diversity indices. (C,D) Non-metric multidimensional scaling (NMDS) based on Bray–Curtis distance of bacterial composition at genus (C) and species (D) level between patients and controls. ** Benjamini–Hochberg adjusted p < 0.05, * Benjamini–Hochberg adjusted p < 0.1.